EBiSC

EBiSC

Details

DC Role: 
Project Partner
Duration: 
1 Jan 2014 - 31 Dec 2017
Client: 
Innovative Medicines Initiative, European Commission (IMI)

ABOUT THIS PROJECT

The goal of European Bank for induced Stem Cells (EBiSC) coordinated by Pfizer Ltd. and managed by Roslin Cells Sciences Ltd. is to establish the supply chain for research-grade human induced pluripotent stem cells (iPSC) with a non-for-profit Biobank in its core.

The Biobank will provide the distribution of disease-relevant quality-controlled iPSC lines, data and services to any qualified user.

Our responsibility is to develop the EBiSC information management system (IMS) and support the business requirement of EBiSC users.

Latest Tweets

Douglas Connect (4 days ago)
RT @LucianFarcal: @EUNanoSafety NSC Meeting and Data Harmonisation Workshop @eNanoMapper @ACEnanoH2020 @NanoFASE_EU #openrisknet https://t.…
Douglas Connect (4 days ago)
RT @EU_ToxRisk: IVAMSS 10/25 Webinar on the dev. and application of #invitro methods and #nonanimal models for #toxicology and product #saf…
Douglas Connect (4 days ago)
RT @barryhardy: #Nano #Safety Cluster community meets to discuss coordinated effort on #datamanagement and #harmonisation #OpenRiskNet #Ope…
Douglas Connect (5 days ago)
RT @iseult5: A proposal for sustainable data infrastructure from @EUNanoSafety #taskforce on sustainability. Presented by Thomas Exner from…
Douglas Connect (2 weeks ago)
RT @EU_ToxRisk: "Save the dates for OpenTox Euro 2017 Meeting" https://t.co/KRJrgD9iH5 on @LinkedIn @DouglasConn @EU_ToxRisk

Get in touch

  • Address: Douglas Connect GmbH
    Technology Park Basel
    Hochbergerstrasse 60C
    CH-4057 Basel / Basel-Stadt
    Switzerland
  • Phone: +41 61 851 0170
  • Email: info@douglasconnect.com